Dihexa: Dihexa has limited safety data
Regular bloodwork and provider check-ins ensure your levels stay optimized and your protocol evolves with you
The new label includes references to some of those postmarketing risks, including intestinal obstruction, [and] severe constipation including fecal impaction. Some patients who took Zepbound have filed lawsuits, accusing Eli Lilly of failing to properly warn them that Zepbound could increase their risk of severe gut problems, including bowel obstructions, pancreatitis, and gastroparesis
Do GLP-1 medications cause loss of hair
Full disclosure of medical history is essential, including any history of seizures, eating disorders, cardiovascular disease, liver or kidney impairment, diabetes, thyroid disorders, or mental health conditions
Type IIIIV users naturally produce more eumelanin and have higher MC1R receptor density, leading to faster visible tanning (58 days) compared to Type III users (1014 days)